Compare glucose tracking with a sensor versus finger sticks
Part of Hormones & metabolism clinical trials.
This study compares two ways to monitor blood sugar after partial or full pancreas removal: a continuous glucose sensor versus traditional finger-stick testing. It looks at both how well blood sugar is controlled and how satisfied people feel with each method.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 19 years old
- You had diabetes before your pancreas surgery
- You had a partial or total pancreatectomy (pancreas removal)
- Your diabetes was diagnosed on the 7th day after surgery based on hormone/endocrine testing
- You have not used a continuous glucose monitoring device more than once before
- You can use a smartphone app (or are comfortable with it)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a continuous glucose monitor (a sensor that tracks glucose) for people with type 1 or type 2 diabetes who receive care at home through Mayo’s Advanced Care at Home program. It may help by improving how safely and accurately blood sugar is followed while you’re at home.
This study compares a continuous glucose monitor (a small sensor on the skin) with the usual fingerstick method for checking blood sugar in hospitalized patients. It aims to see if the sensor is more convenient and just as accurate.
This trial checks how well a continuous glucose monitor works during heart surgery. It aims to help manage blood sugar levels more safely in the operating room.
This study checks whether using a continuous glucose monitor (a sensor that tracks sugar throughout the day) is helpful and practical for people with a recent kidney transplant and type 2 diabetes on insulin. You may need to wear the sensor continuously and still do finger-stick glucose checks for safety.
This trial tests a structured follow-up program to help manage blood sugar levels after pancreatic cancer surgery (Whipple procedure). It uses a continuous glucose monitor app on your smartphone to track glucose and may help you understand how your body regulates sugar after surgery.
This study compares a continuous glucose monitor (CGM) to fingerstick testing for people with type 1 or type 2 diabetes who give themselves insulin injections. It aims to see if using the sensor helps increase the time blood sugar stays in a healthy range.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.